Opinion|Videos|August 6, 2024
Unmet Needs and Future Initiatives
Dr. Tichy discusses unmet needs he deems crucial for the continued uptake of biosimilars.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What are the unmet needs and future initiatives you see as crucial for the continued uptake of biosimilars?
Advertisement
Related to this article
The GOLD International COPD Conference will cover underdiagnosis, exacerbations, mucus, biologics, and a preview of the 2027 GOLD Report.
People with multiple sclerosis make up most of a survey linking variable-friction footwear to fewer self-reported falls.
Clinicians at an AJMC roundtable in Cleveland said Medicare's GLP-1 Bridge came late and that cost and capacity gaps persist.
Nathan Estrada, DPT, explains which patients, including those with multiple sclerosis, may benefit from footwear that adapts to gait.
Patients with Sjögren disease have 5-fold higher odds of depression, yet screening tools remain unvalidated, a new review finds.
Medicare Advantage exits, rising ACA premiums, a Medicare for America bill, and a Medicaid work rule ruling frame health policy on Election Day.
Patient selection raised detection of pathogenic germline variants from 6% to 27% in lung cancer studies.
Pharmacists outline new oncologic therapeutics, from pancreatic cancer to myeloma, and what high prices and crowded markets mean for payers.
Advertisement
Advertisement
Trending on AJMC
1
First-Line Vitiligo Treatment: Topical JAK Inhibitors and Phototherapy
2
Unanswered Questions in First- and Second-Line mCRC Care
3
Planning for Third-Line Therapy and Treatment Rechallenge in mCRC
4
Cleveland Clinicians Say Obesity Care Starts Too Late for Many Patients
5